Dr. Naresh Trehan emphasizes the importance of recognizing personal heart disease risks, highlighting that heart health is influenced by genetics, lifestyle choices, and biomarkers. He advocates for regular exercise, a balanced diet, and stress management as essential components…
Eli Lilly's GLP-1 drug retatrutide has demonstrated remarkable efficacy in aiding individuals with Type 2 diabetes to lose up to 60 pounds, or about 23% of their body weight, acco…
After 14 years as an anesthesiologist, Dr. Tiffany Moon shares her experience of returning to school to study obesity medicine. She reflects on the challenges and joys of being a…
This article analyzes the ingredients and marketing claims of LeeFar, a women's supplement brand known for its weight loss and probiotic products. It raises concerns about the eff…
Dr. Will Cole emphasizes the importance of careful use of GLP-1 medications and peptide therapy, advocating for micro-dosing combined with lifestyle changes rather than high doses…
Emerging research highlights the potential of microdosing GLP-1 receptor agonists, such as semaglutide, during perimenopause to manage metabolic health. This approach may help add…
A recent study from Johns Hopkins Medicine finds that time-restricted eating (TRE) may lead to modest weight loss in adults with obesity and prediabetes. The research, published i…
As prescriptions for GLP-1 medications surge among adolescents, parents face important considerations regarding their children's health. This article explores the benefits and pot…
A recent review examines the effects of GLP-1 medications, particularly semaglutide, on muscle health in postmenopausal women. While these medications can aid in weight loss, they…
This article explores the influence of GLP-1 receptor agonists on self-control and weight management, challenging traditional views that attribute weight issues solely to individu…
In a recent conversation, Dr. Tyna Moore addresses the complexities surrounding GLP-1 medications, advocating for their use at low doses. She counters common misconceptions about…
Research into GLP-1 medications, such as Ozempic and Wegovy, indicates they may play a role in reducing cancer risk by improving metabolic health, but the evidence remains mixed a…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
Beauty companies are racing to address the newly coined term 'Ozempic face' as they develop treatments for facial volume loss linked to rapid weight loss, further complicating the…
Fitness coach Jacob Zemer outlines key strategies to help adults slow muscle loss as they age. He emphasizes the importance of strength training, adequate protein intake, and qual…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…